Literature DB >> 34127427

Fecal short-chain fatty acids and obesity in a community-based Japanese population: The DOSANCO Health Study.

Ryodai Yamamura1, Koshi Nakamura2, Shigekazu Ukawa3, Emiko Okada4, Takafumi Nakagawa5, Akihiro Imae5, Tadao Kunihiro6, Takashi Kimura7, Takumi Hirata7, Akiko Tamakoshi7.   

Abstract

In Western populations, fecal concentrations of short-chain fatty acids (SCFAs) are positively correlated with the prevalence of obesity. However, gut microbiota involved in the production of SCFA varies between races. Our purpose was to investigate the associations between fecal SCFAs and the prevalence of obesity in a community-based Japanese population. We classified a total of 568 participants aged ≥18 into four quartiles of fecal concentrations of SCFA subtypes (acetate, butyrate, and propionate) and total SCFAs to compare the prevalence of obesity, defined as a body mass index ≥ 25.0 kg/m2. Using the first quartile SCFA group as a reference, the prevalence ratios of obesity were calculated for each SCFA group through a log-binomial regression model adjusted for major potentially confounding factors including age, sex, exercise habits, total energy intake, and total dietary fiber intake. In the study population, the prevalence of obesity was 35.8%. The prevalence ratios (95% confidence intervals) of obesity in the second, third, and fourth quartile groups of fecal total SCFAs were 1.30 (0.89-1.89), 1.74 (1.23-2.47) and 1.70 (1.19-2.41), respectively, after adjusting for the confounders. Similar positive associations were observed for every subtype. The prevalence ratios (95% confidence intervals) in the fourth quartile groups of fecal acetate, butyrate, and propionate were 1.41 (1.02-1.97), 2.16 (1.49-3.14), and 1.97 (1.35-2.89), respectively, after adjusting for the confounders. In conclusion, our results demonstrated that fecal SCFA concentrations of every subtype were positively associated with the prevalence of obesity in a community-based Japanese population.
Copyright © 2021 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Fecal short-chain fatty acids; Japanese; Obesity

Year:  2021        PMID: 34127427     DOI: 10.1016/j.orcp.2021.06.003

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  2 in total

1.  NMR-Based Metabolomics to Decipher the Molecular Mechanisms in the Action of Gut-Modulating Foods.

Authors:  Weiwei He; Hanne Christine Bertram
Journal:  Foods       Date:  2022-09-05

2.  Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.

Authors:  Jin Jin; Jiani Wang; Ruyue Cheng; Yan Ren; Zhonghua Miao; Yating Luo; Qingqing Zhou; Yigui Xue; Xi Shen; Fang He; Haoming Tian
Journal:  Front Microbiol       Date:  2022-08-15       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.